Efficacy of first line of bevacizumab in patients with neurofibromatosis 2-related vestibular schwannomas. Koucky V, Jirkovska M, Vlasak A, Kinstova L, et al. Eur Arch Otorhinolaryngol 2025 Oct 6. doi: 10.1007/s00405-025-09734.

Read + Share

Amedeo Smart

Independent Medical Education

Koucky V, Jirkovska M, Vlasak A, Kinstova L, et al. Efficacy of first line of bevacizumab in patients with neurofibromatosis 2-related vestibular schwannomas. Eur Arch Otorhinolaryngol 2025 Oct 6. doi: 10.1007/s00405-025-09734.
PMID: 41053457